Frequency, duration, and cost of pulmonary exacerbations among patients with bronchiectasis

Exacerbations identified using a cost-based algorithm frequently lasted >3 weeks. Patients with cost-based exacerbations had higher healthcare costs, particularly respiratory costs, than those without.

Authors

Institutions

Publication Details

Journal
Journal of Medical Economics
Published
2025-09-29
DOI
https://doi.org/10.1080/13696998.2025.2567761
Citations
1
Primary Topic
Cystic Fibrosis Research Advances
Type
article
Field-Weighted Citation Impact
1.52
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Frequency, duration, and cost of pulmonary exacerbations among patients with bronchiectasis

Joseph Feliciano, Maitreyee Mohanty, R. Rau, Claudia Leiras et al.
1 citations
Journal of Medical Economics
Cystic Fibrosis Research Advances
1.52
article

Frequency, duration, and cost of pulmonary exacerbations among patients with bronchiectasis

Joseph Feliciano, Maitreyee Mohanty, R. Rau, Claudia Leiras, John Fastenau, Sun Haiyan, S.R. Devarajan
article en
1 citations

Abstract

Exacerbations identified using a cost-based algorithm frequently lasted >3 weeks. Patients with cost-based exacerbations had higher healthcare costs, particularly respiratory costs, than those without.

Journal of Medical EconomicsVol. 28(1)
Baylor College of Medicine (US), Insmed (United Kingdom) (GB), Genesis Research Institute (JP)
Openalex Percentile: Top 14%
Cystic Fibrosis Research Advances
1.52
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.